Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation

Neurology

Volumn 52, Issue 4, 1999, Pages 750-756

  Alonso Aperte, Elena ^a   Ubeda, N ^a   Achon M ^a   Perez Miguelsanz J ^b   Varela Moreiras, G ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DNA; FOLINIC ACID; HOMOCYSTEINE; S ADENOSYLMETHIONINE; VALPROIC ACID;

AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FETUS; FOLATE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METHYLATION; MOUSE; NONHUMAN; PATHOGENESIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; TERATOGENICITY;

EID: 0033541022     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.4.750     Document Type: Article

References (42)

1. Bjerkedal T, Czeizel A, Goujard J, et al. Valproic acid and spina bifida. Lancet 1982;ii:1096.
2. Lindhout D, Meinardi H, Meijer JWA, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern malformations. Neurology 1992;45(suppl 5):94-110.
3. Ontzigt JGC, Los FJ, Grobbee DE, et al. The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort. Neurology 1992;42(suppl 5):119-125.
4. Nau H, Spielmann H. Embryotoxicity testing of valproic acid. Lancet 1983;i:763-764.
5. Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 1992;42(suppl 5):17-24.
6. Elmazar MA, Nau H. Trimethoprim potentiates valproic acid induced neural tube defects (NTDs) in mice. Rep Toxicol 1993; 7:249-254.
7. Padmanabhan R, Hameed MS. Exencephaly and axial skeleton malformations induced by maternal administration of sodium valproate in the MF1 mouse. J Craniofac Dev Biol 1994; 14:192-205.
8. Sato M, Shirota M, Nagao T. Pantothenic acid decreases valproic acid induced neural tube defects in mice. Teratology 1995;52:143-148.
9. Menegola E, Broccia ML, Nau H, et al. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratogen Carcinogen Mutagen 1996;16:97-108.
10. Hendel J, Dam M, Gram L, Winkel P, Jorgensen H. The effects of carbamazepine and valproate on folate metabolism in man. Acta Neurol Scand 1984;69:226-231.
11. Smith DB, Carl JF. Interactions between folates and carbamazepine or valproate in the rat. Neurology 1982;32:965-969.
12. Carl GF. Effect of chronic valproate treatment on folate dependent methyl biosynthesis in the rat. Neurochem Res 1986; 11:671-685.
13. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228-237.
14. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. Maternal hyperhomocysteinemia: a risk factor for neural tube defects? Metabolism 1994;43:1475-1480.
15. Mills JL, Scott JM, Kirke PN, et al. Homocysteine and neural tube defects. J Nutr 1996;126:756S-760S.
16. Deulofeu R, Giralt M, Aibar C, et al. Determinación de homocisteína en plasma por cromatografía líquida de alta resolución. Aplicación al estudio de enfermos afectos de enfermedad vascular cerebral y periférica. Quím Clín 1996;15:77-84.
17. Andersson A, Brattstrom L, Isaksson A, Israelsson B, Hultberg B. Determination of homocysteine in plasma by ionexchange chromatography. Scand J Clin Lab Invest 1989;49: 445-450.
18. Fell D, Benjamin LE, Steele RD. Determination of adenosine and adenosyl derivatives of sulfur amino acids in rat liver by high liquid chromatography. J Chromatogr 1985;345:150-156.
19. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J. Folate deficiency-induced homocysteinemia in rats: disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism. Biochem J 1994;298:415-419.
20. Kelleher BP, Broin SDO. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991;45:344-347.
21. Martín-Duce A, Ortiz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988;8:65-68.
22. Finkelstein JD, Mudd SH. Trans-sulfuration in mammals: the methionine-sparing effect of cystine. J Biol Chem 1967;242: 873-880.
23. Keating JN, Weir DG, Scott JM. Demonstration of methionine synthetase activity in the intestinal mucosal cells of the rat. Clin Sci (Lond) 1985;3:287-292.
24. Bradford MM. A rapid and sensitive method for the determination of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
25. Johns MB, Paulus-Thomas JE. Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal Biochem 1989;180:276-278.
26. Christman JK, Weich N, Schoenbrun B, Schneideman N, Asc G. Hypomethylation of DNA during differentiation of Friend erythroleukemia cells. J Cell Biol 1980;86:366-379.
27. Varela-Moreiras G, Alonso-Aperte E, Rubio M, et al. Carbon tetrachloride induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effects of S-adenosylmethionine treatment. Hepatology 1995;22:1310-1315.
28. Ubeda N, Alonso-Aperte E, Achón M, Varela Moreiras G, Puerta J, Pérez de Miguelsanz J. Alteraciones morfológicas en rata gestante inducidas por el valproato y su administración conjunta con ácido folínico o S-adenosilmetionina. Nutrición Hospitalaria 1998;13:41-49.
29. Ubeda N, Alonso E, Martín-Rodriguez JC, et al. Valproate-induced developmental modifications may be partially prevented by coadministration of folinic acid and S-adenosylmethionine. Int J Dev Biol 1996;(suppl 1):291S-292S.
30. Coelho CND, Weber JA, Klein NW, Daniels WG, Hoagland TA. Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J Nutr 1989;119:1716-1725.
31. Coelho CND, Klein NW. Methionine and neural tube closure in cultured rat embryos: morphological and biochemical analyses. Teratology 1990;42:437-451.
32. Steegers-Theunissen RPM, Wathen NC, Eskes TKAB, van Raaij-Selten B, Chard T. Maternal and fetal levels of methionine and homocysteine in early human pregnancy. Br J Obstet Gynaecol 1997;104:20-24.
33. Scott JM. Folate-vitamin B12 interrelationships in the central nervous system. Proc Nutr Soc 1992;51:219-224.
34. Chen Z, Chakraborty S, Banerjee R. Demonstration that mammalian methionine synthases are predominantly cobalamin-loaded. J Biol Chem 1995;270:19246-19249.
35. Selhub J, Rosenberg IH. Folic acid. In: Ziegler EE, Filer LJ, eds. Present knowledge in nutrition. 7th ed. Washington: ILSI Press, 1996:206-219.
36. Hoffmann DR, Cornatzer WE, Duerre JA. Relationship between tissue levels of S-adenosylmethionine, S-adenosylhomocysteine and transmethylation reactions. Can J Biochem 1979;57:56-65.
37. Cabrero C, Martín-Duce A, Ortiz P, Alemany S, Mato JM. Specific loss of high-molecular-weight form of S-adenosylmethionine synthetase in human liver cirrhosis. Hepatology 1988;8:1530-1534.
38. Corrales F, Giménez A, Alvarez L, et al. S-adenosyl methionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthase inactivation and attenuates liver injury. Hepatology 1992;16:1022-1027.
39. Van Aerts LAGJM, Poirot CM, Herberts CA, et al. Development of methionine synthase, cystathionine-β-synthase and S-adenosylhomocysteine hydrolase during gestation in rats. J Rep Fertil 1995;103:227-232.
40. Balaghi M, Wagner C. DNA methylation in folate deficiency: use of CpG methylase. Biochem Biophys Res Comm 1993;193: 1184-1190.
41. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69:915-926.
42. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects [see comments]. Lancet 1995;345:149-151.